Orsiro® Mission DES: BIOSTEMI-ES trial by Dr. Iglesias

3 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Dr. Juan F. Iglesias talks about the BIOSTEMI trial and how the outcomes confirm #OrsiroMission DES as “the new best-in-class and reference for stent comparisons in patients with acute coronary syndrome and mainly STEMI.”
Discover the #BIOSTEMI-ES 5-year follow-up data.
#OrsiroMission DES – Delivering superiority. #WhatWouldYouChoose
#BIOTRONIK #CVI #VI #DES #STEMI
???? For more information please visit: https://en.orsiro.com/
Clinical data collected with the Orsiro device within the Orsiro family clinical program. Orsiro Mission is a trademark or registered trademark of the BIOTRONIK Group of Companies.

© 2025 BIOTRONIK AG – All rights reserved. Specifications are subject to modification, revision and improvement.
Category
Cardiology
Be the first to comment

Up Next